Volunteer Donate Get Help
 

In the News

The latest news reports, articles, and stories that may be of importance to leukemia and lymphoma patients, caregivers, and family members.

Venetoclax Approved for CLL

Published: June 17, 2019

Source: National Cancer Institute

On May 15, 2019, the Food and Drug Administration (FDA) approved venetoclax (Venclexta) in combination with obinutuzumab (Gazyva) for the initial treatment of adults with chronic lymphocytic leukemia (CLL) o ... More >>.


Targeted Therapy Effective Prior to Chemotherapy

Published: June 04, 2019

Source: MD Anderson Cancer Center

Results of a Phase II clinical trial conducted at The University of Texas MD Anderson Cancer Center revealed that combination targeted therapy, consisting of rituximab, lenalidomide and ibrutinib (RLI), had ... More >>.


Patterns of CLL Growth Identified

Published: June 01, 2019

Source: Dana-Farber Cancer Institute

In patients with chronic lymphocytic leukemia (CLL), the rate of disease growth is apt to follow one of three trajectories: relentlessly upward, steadily level, or something in between, scientists at Dana-Fa ... More >>.


Precision Medicine for AML

Published: May 10, 2019

Source: The Leukemia & Lymphoma Society

Precision medicine centers on giving the right treatment to the right patient at the right time based on their genetic information and other characteristics. We are beginning to crack the code to apply preci ... More >>.


Tibsovo Approved to Treat Newly Diagnosed AML

Published: May 03, 2019

Author: Diana Ernest, RPh

Source: Oncology Nurse Advisor

The Food and Drug Administration (FDA) has expanded the indication for Tibsovo to include treatment of newly diagnosed acute myeloid leukemia (AML) with the susceptible isocitrate dehydrogenase-1 (IDH1) muta ... More >>.


Radiotherapy May Improve Survival

Published: April 29, 2019

Source: European Society for Radiotherapy and Oncology (ESTRO)

Patients with advanced Hodgkin's lymphoma who have large tumors at the time of diagnosis may benefit from radiotherapy after chemotherapy even when all traces of the cancer appear to have gone, according to ... More >>.


The Leukemia Atlas

Published: April 17, 2019

Source: University of Texas at San Antonio

Only about one in four people diagnosed with acute myelogenous leukemia (AML) survive five years after initial diagnosis. To improve that survival rate, researchers at The University of Texas at San Antonio ... More >>.


Congress Introduces Cancer Drug Parity Act

Published: March 13, 2019

Source: Leukemia & Lymphoma Society

The Leukemia & Lymphoma Society (LLS) is proud to support the Cancer Drug Parity Act, which will remove a key financial barrier that prevents some patients from accessing their prescribed cancer treatmen ... More >>.


Starving Leukemia Cells by Targeting Amino Acids

Published: March 12, 2019

Source: Emory Health Science

Cancer cells consume sugar at a higher rate than healthy cells, but they're also hungry for amino acids, the building blocks of proteins and other biomolecules. Researchers at Winship Cancer Institute of Emo ... More >>.


Hodgkin Lymphoma Treatment in EU vs US

Published: February 22, 2019

Author: John Schieszer, MA

Source: Oncology Nurse Advisor

Worldwide clinical trials may greatly improve and enhance management of Hodgkin lymphoma, according to a recent article published in Clinical Medicine Insights: Oncology. Thomas J. FitzGerald, MD, a ... More >>.


©2015 Stephanie Robinson Foundation | Privacy Policy